Ceftiofur Sodium

Verify with FDA CVM →

551 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
551
Total Reports
45
Deaths Reported
820.0%
Death Rate

Active Ingredients

Ceftiofur Sodium

Administration Routes

UnknownSubcutaneousIntramuscularIntravenousOtherOralIntra-ArticularOphthalmicIntrauterineParenteral

Species Affected

Unknown 398
Dog 47
Cattle 44
Horse 35
Cat 12
Goat 3
Pig 3
Human 3
Sheep 3
Other 2

Most Affected Breeds

Unknown 403
Holstein-Friesian also known as Holstein 20
Cattle (other) 13
Horse (unknown) 9
Quarter Horse 7
Domestic Shorthair 7
Retriever - Labrador 5
Warmblood (unspecified) 5
Domestic (unspecified) 4
Cattle (unknown) 4

Most Reported Reactions

Suspension, Abnormal 141
Solution, Abnormal 127
Color, Abnormal 118
Precipitate, Sediment 108
No sign 37
Death 25
Uncoded sign 21
Lack of efficacy - NOS 20
Contamination, Foreign Object 19
Granules/Powder, Abnormal 16
Appearance, Abnormal 15
Residues in meat/offal 14

Outcome Breakdown

Outcome Unknown
42 (30.7%)
Died
29 (21.2%)
Ongoing
25 (18.2%)
Recovered/Normal
24 (17.5%)
Euthanized
17 (12.4%)

Data Summary

Metric Value
Total adverse event reports 551
Reports involving death 45
Case-fatality rate (reported events) 820.0%
Distinct species in reports 10
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ceftiofur Sodium Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 551 adverse event reports referencing Ceftiofur Sodium, including 45 reports in which the animal died — a 820.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ceftiofur Sodium. Reported administration routes include Unknown, Subcutaneous, Intramuscular, Intravenous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ceftiofur Sodium reports are Unknown (398 reports), Dog (47 reports), Cattle (44 reports), with Unknown accounting for the largest share. Within those species, Unknown (403), Holstein-Friesian also known as Holstein (20), Cattle (other) (13) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ceftiofur Sodium are Suspension, Abnormal (141), Solution, Abnormal (127), Color, Abnormal (118), Precipitate, Sediment (108). Of the 137 reports with a coded outcome, Outcome Unknown is the leading category at 30.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ceftiofur Sodium.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial